Oncogenesis addiction, biomarkers: Who should be tested and when?

Date 27 September 2014
Event ESMO 2014
Session Systemic treatment of metastatic NSCLC
Topics Anticancer agents
Personalised/Precision medicine
Non-small-cell lung cancer
Basic Principles in the Management and Treatment (of cancer)
Therapy
Biological therapy
Presenter Pasi Janne
Authors P.A. Janne
  • Thoracic Oncology, Dana-Farber Cancer Institute, 02215 - Boston/US